THERAPEUTIC AGENT FOR MEIBOMIAN DYSFUNCTION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20180021314A1
SERIAL NO

15722257

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for treatment of meibomian gland dysfunction in a mammalian subject, the method involving administering to the mammalian subject an eye drop comprising 0.01 to 0.5% (w/v) of sirolimus or a pharmaceutically acceptable salt thereof as a sole active ingredient, wherein the eye drop is administered to the eyes of the mammalian subject 1 to 2 times per day.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANTEN PHARMACEUTICAL CO LTDOSAKA

International Classification(s)

loading....
  • 2017 Application Filing Year
  • A61K Class
  • 21227 Applications Filed
  • 12841 Patents Issued To-Date
  • 60.50 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances2017201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
MIYAKE, Hideki lkoma-shi, JP 22 194
ODA, Tomoko lkoma-shi, JP 22 46
SHII, Daisuke lkoma-shi, JP 10 36

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 1 Citation Count
  • A61K Class
  • 50.93 % this patent is cited more than
  • 7 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges92918022655157761477225301 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +050010001500200025003000350040004500500055006000650070007500800085009000950010000

Forward Cite Landscape

Load Citation